B·R·A·H·M·S Free βhCG KRYPTOR
- Outstanding precision: UK NEQAS data 2003-2021 proof mean CV of 2.9% Ref-1
- Short assay time
- In routine use by FMF since 1999
Clinical indication
The B·R·A·H·M·S Free β hCG KRYPTOR test is an automated immunofluorescent assay for the quantitative determination of the concentration of free β hCG (free beta subunit of human chorionic gonadotropin hormone) in human serum. The B·R·A·H·M·S Free βhCG KRYPTOR test is indicated as an aid to be used in conjunction with other clinical and diagnostic findings for non-invasive risk assessment of fetal trisomy 21, 18, and 13 in first trimester and for fetal trisomy 21 and 18 in second trimester in pregnant women.
Ease of handling
| Sample volume | 26 µL |
| Sample type | Serum |
| Incubation time | 19 min |
| Linear direct measuring range | 0.74 to 150 IU/L |
| Upper measuring range with automatic dilution | up to 50 000 IU/L |
| Limit of detection | 0.09 IU/L |
| Kit stability on board | 29 days |
| Calibrator | 1 point |
| Calibration stability | 15 days |
Excellent precision
Our B·R·A·H·M·S Free βhCG KRYPTOR assay offers highly precise measurements and a consistent and excellent long-term performance, therefore making KRYPTOR platform the instrument of choice in first trimester screening.
Instruments
B·R·A·H·M·S Free βhCG KRYPTOR is available on:
Kit and accessories
| Article number | Description |
| 809.075N |
B·R·A·H·M·S Free βhCG KRYPTOR Kit, reagents for 75 determinations |
| 80991N |
B·R·A·H·M·S Free βhCG KRYPTOR CAL Calibrator kit, 6 vials |
| 88192N |
B·R·A·H·M·S GM KRYPTOR QC Control kit prenatal screening, 3 levels (2 vials per level) |
Further links on prenatal screening products and assays
- Download the B·R·A·H·M·S Free βhCG KRYPTOR product sheet.
- Download our brochure about first trimester combined screening.
- Download our literature review about contingent screening.
- Find here all our prenatal screening brochures, product sheets and other informational material.
References B·R·A·H·M·S Free βhCG KRYPTOR
Ref-1: Monthly UK NEQAS reports, February 2003 - November 2021.